Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Helicobacter Pylori Eradication on Gastric Cancer Prevention in Korea: a Randomized Controlled Clinical Trial

NCT02112214 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT02112214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Helicobacter Pylori Eradication on Gastric Cancer Prevention in Korea: a Randomized Controlled Clinical Trial
Lead sponsor
National Cancer Center, Korea
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 30, 2014
Completion date
December 31, 2029
Enrollment
5,224 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, helicobacter pylori infection